Healthcare -
Biotechnology - NASDAQ - US
$ 47.58
-3.14 %
$ 3.57 B
Market Cap
-12.69
P/E
AKRO - TOTAL CURRENT LIABILITIES
Total Current Liabilities AKRO - Akero Therapeutics, Inc.
19.1 M
LAST VALUE
-12.75%
2 YEAR CAGR
52.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR